Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-2.78	37.83	38.91
Graham Fair Price	< 0.005	0.44	0.44
PEG	inf	0.00	0.93
Price/Book	-4.29	2.33	2.43
Price/Cash Flow	-4.29	76.44	79.86
Prices/Earnings	-4.29	16.65	17.39
Price/Sales	-4.29	7.43	7.77
Price/FCF	-4.29	76.44	79.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.24	0.24
Operating Margin	0.00	0.15	0.15
ROA	0.00	0.01	0.01
ROE	0.03	0.03	< 0.005
ROIC	0.02	0.02	-1.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.03	< 0.005	1030.55
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.63	0.00	inf
EPS QOQ	0.19	0.00	inf
FCF QOQ	1.70	0.00	inf
Revenue QOQ	0.29	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	24.25	24.25	0.00
Days Sales Outstanding (DSO)	155.18	155.18	0.00
Inventory Turnover	3.71	3.71	0.00
Debt/Capitalization	0.46	0.47	1.73
Quick Ratio	1.47	1.48	0.76
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.49	0.49	< 0.005
Cash	0.35	0.35	1.33
Capex	-0.02	-0.02	0.00
Free Cash Flow	0.01	0.01	0.00
Revenue	0.15	0.15	0.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.70	1.70	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.26	2.75	21.74
Naive Interpretation	Member

06 - Financial Health · Weak

Rating